Get a Quote

BF-ESSE Nominated for Life Sciences Category — Rīgas Gada Uzņēmums 2025









BF-ESSE has been nominated in the Life Sciences category at Rīgas Gada Uzņēmums 2025 — an annual recognition program highlighting companies contributing to innovation, economic development, and technological progress in Latvia.
For us, this nomination reflects the work behind our growth in nutraceutical manufacturing and the increasing relevance of clean-label, compliant, scalable supplement production in Europe.


Why This Matters
Being nominated in the Life Sciences category places BF-ESSE among companies shaping the future of Latvia’s science-driven industries.
It demonstrates that our work in:
  • formulation development
  • European compliance
  • precision manufacturing
  • scalable private-label and white-label solutions
is recognized as part of the broader Life Sciences ecosystem.
Industry Context
The nutraceutical sector is rapidly evolving — shifting toward quality, transparency, and regulatory alignment.

Our nomination signals that:

clean-label supplement formulation matters
compliant production matters
innovation in nutraceuticals can grow in the Baltics
and Latvia has a place in Europe’s health & wellness manufacturing landscape.
A Step Forward — Not the Finish Line
Although we did not take the award this year, the nomination itself is meaningful: it validates the direction and confirms that the strategy, execution, and pace of development are aligned with the needs of the industry.
This milestone motivates us to continue expanding R&D capabilities, scaling manufacturing infrastructure, and supporting European wellness brands as a trusted CMO partner.
BF-EssE team at Rīgas Gada Uzņēmums 2025
We welcome any brand or entrepreneur who wants to explore how advanced manufacturing, high‑value ingredients and forward‑looking strategy come together. Connect with us and let’s build the next generation of supplements — together.